文献速递骨质疏松与代谢性骨病

七种骨质疏松筛查工具的综合评价

A comprehensive evaluation of seven osteoporosis screening tools.
PubMed 文献 · Osteoporos Int · 2026-07-20

本综述评估了OSTA、OST、ORAI、SCORE、ABONE、SOFSURF和OSIRIS七种骨质疏松筛查工具在绝经后女性、老年人和特定疾病患者中的灵敏度、特异度及预测值。多数工具灵敏度高、成本效益好,但特异度低导致大量假阳性;机器学习有望通过整合多维数据提升筛查性能,但证据尚初步,需进一步验证。

要点

  • 七种筛查工具多数灵敏度高,利于骨质疏松早期发现。
  • 共同局限是特异度低,易将大量受试者误判为高风险。
  • 机器学习整合多维数据有望提升筛查性能,但证据尚初步。

核心结论

  • 七种骨质疏松筛查工具多数灵敏度高、成本效益好且可适应不同疾病特征,但特异度低导致假阳性常见。
  • 机器学习有望通过整合多维数据和处理大规模样本克服传统局限,但证据尚初步,需更多高质量研究验证后方可广泛临床应用。

研究设计与样本

  • 在PubMed、Web of Science和CNKI检索过去25年关于七种目标筛查工具的研究。
  • 纳入经同行评议的原创研究(横断面研究、前瞻性队列研究和诊断验证研究),排除综述、荟萃分析、动物研究、非临床研究和非英文文章。

主要发现

  • 七种工具多数灵敏度高,便于骨质疏松早期检测,并具有成本效益和适应不同疾病特征的优点。
  • 这些工具存在明显局限,主要是特异度低,常导致假阳性结果。
  • 机器学习通过整合多维数据和处理大规模数据集显示出改善筛查性能的潜力,但证据尚初步,需进一步验证。

关键数值与推荐

  • 评估的七种工具为OSTA、OST、ORAI、SCORE、ABONE、SOFSURF和OSIRIS。
  • 总结的关键指标包括灵敏度、特异度、阳性预测值和阴性预测值。
  • 应用人群包括绝经后女性、老年人和特定疾病患者。

临床怎么用

  • 可利用七种工具的高灵敏度进行骨质疏松早期筛查,但需警惕低特异度带来的假阳性。
  • 机器学习筛查策略在广泛临床应用前仍需更多高质量研究验证。

局限性

  • 七种筛查工具特异度低,常导致假阳性结果。
  • 机器学习改善筛查性能的证据尚初步,需进一步验证。
  • 多模态人工智能与电子健康记录整合作为未来方向,仍需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This review evaluates the sensitivity, specificity, and predictive values of seven osteoporosis screening tools in populations such as postmenopausal women, older adults, and patients with specific diseases. These tools offer advantages, including high sensitivity (facilitating early detection of osteoporosis), high cost-effectiveness, and the ability to be customized according to disease characteristics. However, they commonly suffer from low specificity, leading to a large number of subjects being misclassified as high-risk. This review identifies that the application of machine learning holds promise for improving the performance of screening tools. By integrating multidimensional data and processing large-scale sample data, machine learning is expected to overcome traditional limitations and comprehensively improve the efficiency of osteoporosis screening. In the future, integrating multimodal artificial intelligence with electronic health records may enable more accurate, comprehensive prediction of osteoporosis. This review summarizes the current strengths and limitations of osteoporosis screening tools and proposes directions for optimization and future research. OBJECTIVE: This study focuses on seven osteoporosis screening tools: Osteoporosis Self-Assessment Tool for Asians (OSTA), Osteoporosis Self-Assessment Tool (OST), Osteoporosis Risk Assessment Instrument (ORAI), Simple Calculated Osteoporosis Risk Estimation (SCORE), A Simple Bone Health Evaluation Tool (ABONE), Simple Osteoporosis Fracture Risk Tool for Seniors (SOFSURF), and Osteoporosis Self-Report Instrument for Identification of Seniors at Risk (OSIRIS). It summarizes key indicators such as their sensitivity, specificity, positive predictive value, and negative predictive value, aiming to evaluate their application performance in different populations, including postmenopausal women, older adults, and patients with specific diseases, and discusses the current advantages and dilemmas of osteoporosis screening tools. METHOD: A literature search was conducted in PubMed, Web of Science, and CNKI for studies on the seven target osteoporosis screening tools published over the past 25 years. The inclusion criteria included peer-reviewed original research articles (cross-sectional studies, prospective cohort studies, and diagnostic validation studies), excluding reviews, meta-analyses, animal studies, non-clinical studies, and non-English articles. RESULT: Most of the seven screening tools demonstrate high sensitivity, facilitating early detection of osteoporosis and offering advantages such as cost-effectiveness and adaptability to diverse disease characteristics. However, these tools have obvious limitations, primarily low specificity, which often leads to false-positive results. Machine learning shows potential to improve screening performance by integrating multidimensional data and processing large-scale datasets, though the evidence remains preliminary and requires further validation. The integration of multimodal artificial intelligence and electronic health records is proposed as a future direction, but it requires further validation. CONCLUSION: Based on existing evidence, the advantages and limitations of seven osteoporosis screening tools were summarized. It was noted that more high-quality research is needed to validate novel screening strategies (such as machine learning-based models) before their widespread clinical application.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Duan Z, Liu J, et al. A comprehensive evaluation of seven osteoporosis screening tools. Osteoporos Int. 2026. PMID: 42477227. doi:10.1007/s00198-026-08118-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。